• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1142

Brazzein produced by Komagataella phaffii expressing a gene encoding for brazzein from Pentadiplandra brazzeana

Intended Use: Intended for use as a sweetener at maximum levels ranging from 2 to 99 mg/100 g in packaged alcoholic cocktail drinks; packaged water-based beverages; non-milk-based meal replacement beverages and protein drinks; chewing gum; ready-to-drink coffee and tea beverages; milk substitutes; non-dairy yogurts; ice cream; frozen yogurt; frozen milk desserts and bars; edible ices; sherbet; sorbet; cereal, granola, energy, protein, and meal replacement bars; granola; packaged milk-based beverages; yogurt and yogurt drinks; packaged fruit drinks, nectars, and fruit-based smoothies; fruit-based bars; truffles; and gummy bears.
Basis: Scientific procedures
Notifier: Oobli, Inc.
Notifier Address: 202 Cousteau Place, Suite 210
Davis, CA 95618
GRAS Notice (releasable information): GRN 1142 with amendments (in PDF) (7 MB)
Date of closure: Mar 11, 2024
FDA's Letter: FDA has no questions (in PDF) (257 kB)